Update on the treatment of diabetic foot infections.
This article brings the practicing clinician up to date on the current concepts regarding the medical treatment of diabetic foot infections. Topics include a review of the Infectious Diseases Society of America Practice Guidelines for the Diagnosis and Treatment of Diabetic Foot Infections and a discussion of newer antibiotics such as linezolid, ertapenem, moxifloxacin, dalbavancin, tigecycline, ceftobiprole and iclaprim.
Kosinski
Mark A
MA
Department of Medicine, New York College of Podiatric Medicine, 1800 Park Avenue, New York, NY 10035, USA. mkosins@nycpm.edu
Joseph
Warren S
WS
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D017719:Diabetic Foot / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D016106:Methicillin Resistance; D010019:Osteomyelitis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D017410:Practice Guidelines as Topic; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology; D013211:Staphylococcus aureus / Q000187:drug effects
D000900:Anti-Bacterial Agents